SE8001620L - BRAND CAPTAICYL DERIVATIVES OF KETOSUBSTITUTED PROLINIC AND PIPECOLIC ACID - Google Patents

BRAND CAPTAICYL DERIVATIVES OF KETOSUBSTITUTED PROLINIC AND PIPECOLIC ACID

Info

Publication number
SE8001620L
SE8001620L SE8001620A SE8001620A SE8001620L SE 8001620 L SE8001620 L SE 8001620L SE 8001620 A SE8001620 A SE 8001620A SE 8001620 A SE8001620 A SE 8001620A SE 8001620 L SE8001620 L SE 8001620L
Authority
SE
Sweden
Prior art keywords
lower alkyl
ketosubstituted
captaicyl
prolinic
brand
Prior art date
Application number
SE8001620A
Other languages
Swedish (sv)
Other versions
SE431331B (en
Inventor
M A Ondetti
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Priority claimed from BE0/199891A external-priority patent/BE882366A/en
Publication of SE8001620L publication Critical patent/SE8001620L/en
Publication of SE431331B publication Critical patent/SE431331B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention is directed to compounds of the formula <IMAGE> or a physiologically acceptable salt thereof, wherein R is hydrogen or lower alkyl, R1 and R3 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkylthio, -(CH2)n-SH, and halo substituted lower alkyl; R2 is hydrogen or lower alkyl provided that R2 is lower alkyl only when R1 is lower alkyl; m is zero, one or two; n is one, two or three; p and q are each one or two provided that both are not two; and R4 is hydrogen, a hydrolyzably removable protecting group, a chemically removable protecting group, or provided that neither R1 nor R3 is -(CH2)n-SH, <IMAGE> which are useful in the treatment of hypertension.
SE8001620A 1980-03-21 1980-02-29 NEW THERAPEUTICALLY ACTIVE SULFUR CONTAINING N-ACYLATED DERIVATIVES OF 4-OXO-L-PROLINE SE431331B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE0/199891A BE882366A (en) 1980-03-21 1980-03-21 MERCAPTOACYL DERIVATIVES OF PROLINE AND PIPECOLIC ACID WITH KETONIC FUNCTION, THEIR PREPARATION AND THEIR USE

Publications (2)

Publication Number Publication Date
SE8001620L true SE8001620L (en) 1981-08-30
SE431331B SE431331B (en) 1984-01-30

Family

ID=3843313

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001620A SE431331B (en) 1980-03-21 1980-02-29 NEW THERAPEUTICALLY ACTIVE SULFUR CONTAINING N-ACYLATED DERIVATIVES OF 4-OXO-L-PROLINE

Country Status (9)

Country Link
JP (1) JPS56133261A (en)
AT (1) AT371436B (en)
CH (1) CH645619A5 (en)
DE (1) DE3009684A1 (en)
FR (1) FR2478632A1 (en)
GB (1) GB2070586A (en)
NL (1) NL8001599A (en)
PT (1) PT70988A (en)
SE (1) SE431331B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258853A (en) * 1982-04-30 1989-08-29 Rudiger D. Haugwitz Substituted 4-phenoxy prolines
JP2007262017A (en) * 2006-03-29 2007-10-11 Ajinomoto Co Inc Antidiabetic composition containing pipecolic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
JPS55147257A (en) * 1979-05-04 1980-11-17 Ono Pharmaceut Co Ltd Pyroglutamic acid derivative, its preparation and pharmaceutical composition containing it as effective component

Also Published As

Publication number Publication date
FR2478632B1 (en) 1983-08-26
FR2478632A1 (en) 1981-09-25
ATA147080A (en) 1982-11-15
PT70988A (en) 1980-09-16
JPH0140827B2 (en) 1989-08-31
JPS56133261A (en) 1981-10-19
NL8001599A (en) 1981-10-16
AT371436B (en) 1983-06-27
GB2070586A (en) 1981-09-09
DE3009684A1 (en) 1981-09-24
CH645619A5 (en) 1984-10-15
SE431331B (en) 1984-01-30

Similar Documents

Publication Publication Date Title
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
NO174389C (en) Plant-protecting triazole and imidazole compounds and their use
SE7906722L (en) BRAND CAPTAICYL DERIVATIVES OF SUBSTITUTED PROLINES
SE8503888D0 (en) HETEROCYCLIC DERIVATIVES
IL97760A0 (en) Substituted azoles,processes for the preparation thereof,compositions containing these,and the use thereof
DK0450812T3 (en) Antihypercholesterolemia
AU575306B2 (en) Proline derivatives
ES2193241T3 (en) NEW N-2-OXO2.3.4.5-TETRAJODRP-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
FI943508A0 (en) Pyridinecarboxymidamide compounds and their use
NO840037L (en) CYCLOALIFATIC PHARMASOEYTIC COMPOUNDS
DK358983D0 (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE DERIVATIVES
EP0251014A3 (en) 2-trifluoromethyl benzimidazoles
DE69330601D1 (en) SEROTON INERGIC ERGOLIN DERIVATIVES
SE8001620L (en) BRAND CAPTAICYL DERIVATIVES OF KETOSUBSTITUTED PROLINIC AND PIPECOLIC ACID
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
ES2066756T3 (en) NEW DERIVATIVES OF TIRONINA.
DE69413112D1 (en) 5-HT3 pyrrolopyrazine derivatives
DE3369324D1 (en) Thiolphosphoric-acid esters, their preparation and use
JPS5519268A (en) Pyrimidine derivative and medical composition
TW275629B (en)
GR78773B (en)
ES501744A0 (en) PROCEDURE FOR OBTAINING N-ALCOHYL-DIALCANOLAMINES BIS (SUBSTITUTED PHENOXYACETATES)
ES2077697T3 (en) DERIVATIVES OF 1-PHENOXICARBONYL-2-PYRROLIDINONE AND NOOTROPIC AGENTS.
GR3005867T3 (en)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8001620-7

Effective date: 19921005

Format of ref document f/p: F